Table 1 Descriptive statistics of the study population (n = 251)
Clinicopathological features | Mean ± SD/n(%) |
|---|---|
Gender | |
Male | 139(55.4) |
Female | 112(44.6) |
Age (years) | |
Mean ± SD | 51.65 ± 10.03 |
Age groups | |
≤ 40 years | 37(14.7) |
41–50 years | 68(27.1) |
51–60 years | 114(45.4) |
> 60 years | 32(12.8) |
Disease duration (months) | |
Mean ± SD | 4.35 ± 1.01 |
Disease duration, group | |
≤ 4 months | 122 (48.6) |
> 4 months | 129(51.4) |
Tumor stage | |
Stage-I | 88(35.0) |
Stage-II | 123(49) |
Stage-III | 24(9.6) |
Stage-IV | 16(6.4) |
Tumor grade | |
Grade 1 | 71(28.3) |
Grade 2 | 141(56.2) |
Grade 3 | 39(15.5) |
Frozen section margin status | |
Positive | 125(49.8) |
Negative | 126(50.2) |
Final (paraffin) margin status | |
Positive | 134(53.4) |
Negative | 117(46.6) |